Trials / Unknown
UnknownNCT03675425
The Effects of Phototherapy in Preterm Infants Pda
Chest Shielding for Prevention of a Patent Ductus Arteriosus in Preterm Infants Receiving Phototherapy Effect of Phototherapy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
- Sex
- All
- Age
- 3 Days – 1 Week
- Healthy volunteers
- Not accepted
Summary
The study was designed to assess whether chest shielding during phototherapy reduces the incidence of PDA, as assessed by serial echocardiographic examinations, in a population of extremely preterm infants born at lower 30 week gestation.
Detailed description
Phototherapy is a therapeutic intervention frequently used for management of neonatal hyperbilirubinaemia in extremely premature infants, especially in the first week when patency of the ductus is a clinical problem. Phototherapy has also been implicated in increased ductal patency. One randomized, controlled trial showed that chest shielding during phototherapy reduced the incidence and severity of PDA by 50% in preterm infants. These findings were mainly based on clinical evaluation of the ductus with echocardiographic studies performed only on a subgroup of infants noted to have a murmur on clinical examination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Group 1: non chest shielding | non chest childin: infants will be randomized into two different phototherapy groups eco with pad diameter will be measured in before and after phototherapy, |
| OTHER | Group 2: chest shielding | chest childing: infants will be randomized into two different phototherapy groups eco with pad diameter will be measured in before and after phototherapy, |
Timeline
- Start date
- 2018-07-08
- Primary completion
- 2019-01-30
- Completion
- 2019-02-28
- First posted
- 2018-09-18
- Last updated
- 2018-12-11
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03675425. Inclusion in this directory is not an endorsement.